TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant July 11, 2014
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs. March 26, 2004